A patent review of RAF kinase inhibitors (2010–2018)
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2019.1651842
Abstract: ABSTRACT Introduction: RAF kinase inhibitors block and regulate RAS/RAF/MEK/ERK signaling, which is a key to tumor treatment. At present, although RAF kinase inhibitors have good efficacy, there are few such drugs with low toxicity, and… read more here.
Keywords: kinase inhibitors; 2010 2018; kinase; raf kinase ... See more keywords